0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biologics in Spine Surgery Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-13S10636
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Biologics in Spine Surgery Market Research Report 2022
BUY CHAPTERS

Global Biologics in Spine Surgery Market Research Report 2025

Code: QYRE-Auto-13S10636
Report
February 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biologics in Spine Surgery Market Size

The global market for Biologics in Spine Surgery was valued at US$ 2349 million in the year 2024 and is projected to reach a revised size of US$ 3290 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Biologics in Spine Surgery Market

Biologics in Spine Surgery Market

Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biologics in Spine Surgery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics in Spine Surgery.
The Biologics in Spine Surgery market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biologics in Spine Surgery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics in Spine Surgery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Biologics in Spine Surgery Market Report

Report Metric Details
Report Name Biologics in Spine Surgery Market
Accounted market size in year US$ 2349 million
Forecasted market size in 2031 US$ 3290 million
CAGR 5.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Bone Graft
  • Bone Graft Substitute
  • Platelet Rich Plasma (PRP)
  • Other
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medtronic, J & J, Stryker Corporation, Nuvasive, Zimmer Biomet, Orthofix International, Globus Medical, alphatec spine, K2M, Exactech, Wright Medical Technology, X-Spine, Nutech, Arthrex
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Biologics in Spine Surgery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Biologics in Spine Surgery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Biologics in Spine Surgery Market growing?

Ans: The Biologics in Spine Surgery Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Biologics in Spine Surgery Market size in 2031?

Ans: The Biologics in Spine Surgery Market size in 2031 will be US$ 3290 million.

Who are the main players in the Biologics in Spine Surgery Market report?

Ans: The main players in the Biologics in Spine Surgery Market are Medtronic, J & J, Stryker Corporation, Nuvasive, Zimmer Biomet, Orthofix International, Globus Medical, alphatec spine, K2M, Exactech, Wright Medical Technology, X-Spine, Nutech, Arthrex

What are the Application segmentation covered in the Biologics in Spine Surgery Market report?

Ans: The Applications covered in the Biologics in Spine Surgery Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Biologics in Spine Surgery Market report?

Ans: The Types covered in the Biologics in Spine Surgery Market report are Bone Graft, Bone Graft Substitute, Platelet Rich Plasma (PRP), Other

1 Biologics in Spine Surgery Market Overview
1.1 Product Definition
1.2 Biologics in Spine Surgery by Type
1.2.1 Global Biologics in Spine Surgery Market Value Comparison by Type (2024 VS 2031)
1.2.2 Bone Graft
1.2.3 Bone Graft Substitute
1.2.4 Platelet Rich Plasma (PRP)
1.2.5 Other
1.3 Biologics in Spine Surgery by Application
1.3.1 Global Biologics in Spine Surgery Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Biologics in Spine Surgery Market Size Estimates and Forecasts
1.4.1 Global Biologics in Spine Surgery Revenue 2020-2031
1.4.2 Global Biologics in Spine Surgery Sales 2020-2031
1.4.3 Global Biologics in Spine Surgery Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Biologics in Spine Surgery Market Competition by Manufacturers
2.1 Global Biologics in Spine Surgery Sales Market Share by Manufacturers (2020-2025)
2.2 Global Biologics in Spine Surgery Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Biologics in Spine Surgery Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Biologics in Spine Surgery, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biologics in Spine Surgery, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biologics in Spine Surgery, Product Type & Application
2.7 Global Key Manufacturers of Biologics in Spine Surgery, Date of Enter into This Industry
2.8 Global Biologics in Spine Surgery Market Competitive Situation and Trends
2.8.1 Global Biologics in Spine Surgery Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Biologics in Spine Surgery Players Market Share by Revenue
2.8.3 Global Biologics in Spine Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Biologics in Spine Surgery Market Scenario by Region
3.1 Global Biologics in Spine Surgery Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Biologics in Spine Surgery Sales by Region: 2020-2031
3.2.1 Global Biologics in Spine Surgery Sales by Region: 2020-2025
3.2.2 Global Biologics in Spine Surgery Sales by Region: 2026-2031
3.3 Global Biologics in Spine Surgery Revenue by Region: 2020-2031
3.3.1 Global Biologics in Spine Surgery Revenue by Region: 2020-2025
3.3.2 Global Biologics in Spine Surgery Revenue by Region: 2026-2031
3.4 North America Biologics in Spine Surgery Market Facts & Figures by Country
3.4.1 North America Biologics in Spine Surgery Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Biologics in Spine Surgery Sales by Country (2020-2031)
3.4.3 North America Biologics in Spine Surgery Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Biologics in Spine Surgery Market Facts & Figures by Country
3.5.1 Europe Biologics in Spine Surgery Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Biologics in Spine Surgery Sales by Country (2020-2031)
3.5.3 Europe Biologics in Spine Surgery Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biologics in Spine Surgery Market Facts & Figures by Region
3.6.1 Asia Pacific Biologics in Spine Surgery Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Biologics in Spine Surgery Sales by Region (2020-2031)
3.6.3 Asia Pacific Biologics in Spine Surgery Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Biologics in Spine Surgery Market Facts & Figures by Country
3.7.1 Latin America Biologics in Spine Surgery Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Biologics in Spine Surgery Sales by Country (2020-2031)
3.7.3 Latin America Biologics in Spine Surgery Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biologics in Spine Surgery Market Facts & Figures by Country
3.8.1 Middle East and Africa Biologics in Spine Surgery Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Biologics in Spine Surgery Sales by Country (2020-2031)
3.8.3 Middle East and Africa Biologics in Spine Surgery Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Biologics in Spine Surgery Sales by Type (2020-2031)
4.1.1 Global Biologics in Spine Surgery Sales by Type (2020-2025)
4.1.2 Global Biologics in Spine Surgery Sales by Type (2026-2031)
4.1.3 Global Biologics in Spine Surgery Sales Market Share by Type (2020-2031)
4.2 Global Biologics in Spine Surgery Revenue by Type (2020-2031)
4.2.1 Global Biologics in Spine Surgery Revenue by Type (2020-2025)
4.2.2 Global Biologics in Spine Surgery Revenue by Type (2026-2031)
4.2.3 Global Biologics in Spine Surgery Revenue Market Share by Type (2020-2031)
4.3 Global Biologics in Spine Surgery Price by Type (2020-2031)
5 Segment by Application
5.1 Global Biologics in Spine Surgery Sales by Application (2020-2031)
5.1.1 Global Biologics in Spine Surgery Sales by Application (2020-2025)
5.1.2 Global Biologics in Spine Surgery Sales by Application (2026-2031)
5.1.3 Global Biologics in Spine Surgery Sales Market Share by Application (2020-2031)
5.2 Global Biologics in Spine Surgery Revenue by Application (2020-2031)
5.2.1 Global Biologics in Spine Surgery Revenue by Application (2020-2025)
5.2.2 Global Biologics in Spine Surgery Revenue by Application (2026-2031)
5.2.3 Global Biologics in Spine Surgery Revenue Market Share by Application (2020-2031)
5.3 Global Biologics in Spine Surgery Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Biologics in Spine Surgery Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Medtronic Biologics in Spine Surgery Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 J & J
6.2.1 J & J Company Information
6.2.2 J & J Description and Business Overview
6.2.3 J & J Biologics in Spine Surgery Sales, Revenue and Gross Margin (2020-2025)
6.2.4 J & J Biologics in Spine Surgery Product Portfolio
6.2.5 J & J Recent Developments/Updates
6.3 Stryker Corporation
6.3.1 Stryker Corporation Company Information
6.3.2 Stryker Corporation Description and Business Overview
6.3.3 Stryker Corporation Biologics in Spine Surgery Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Stryker Corporation Biologics in Spine Surgery Product Portfolio
6.3.5 Stryker Corporation Recent Developments/Updates
6.4 Nuvasive
6.4.1 Nuvasive Company Information
6.4.2 Nuvasive Description and Business Overview
6.4.3 Nuvasive Biologics in Spine Surgery Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Nuvasive Biologics in Spine Surgery Product Portfolio
6.4.5 Nuvasive Recent Developments/Updates
6.5 Zimmer Biomet
6.5.1 Zimmer Biomet Company Information
6.5.2 Zimmer Biomet Description and Business Overview
6.5.3 Zimmer Biomet Biologics in Spine Surgery Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Zimmer Biomet Biologics in Spine Surgery Product Portfolio
6.5.5 Zimmer Biomet Recent Developments/Updates
6.6 Orthofix International
6.6.1 Orthofix International Company Information
6.6.2 Orthofix International Description and Business Overview
6.6.3 Orthofix International Biologics in Spine Surgery Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Orthofix International Biologics in Spine Surgery Product Portfolio
6.6.5 Orthofix International Recent Developments/Updates
6.7 Globus Medical
6.7.1 Globus Medical Company Information
6.7.2 Globus Medical Description and Business Overview
6.7.3 Globus Medical Biologics in Spine Surgery Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Globus Medical Biologics in Spine Surgery Product Portfolio
6.7.5 Globus Medical Recent Developments/Updates
6.8 alphatec spine
6.8.1 alphatec spine Company Information
6.8.2 alphatec spine Description and Business Overview
6.8.3 alphatec spine Biologics in Spine Surgery Sales, Revenue and Gross Margin (2020-2025)
6.8.4 alphatec spine Biologics in Spine Surgery Product Portfolio
6.8.5 alphatec spine Recent Developments/Updates
6.9 K2M
6.9.1 K2M Company Information
6.9.2 K2M Description and Business Overview
6.9.3 K2M Biologics in Spine Surgery Sales, Revenue and Gross Margin (2020-2025)
6.9.4 K2M Biologics in Spine Surgery Product Portfolio
6.9.5 K2M Recent Developments/Updates
6.10 Exactech
6.10.1 Exactech Company Information
6.10.2 Exactech Description and Business Overview
6.10.3 Exactech Biologics in Spine Surgery Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Exactech Biologics in Spine Surgery Product Portfolio
6.10.5 Exactech Recent Developments/Updates
6.11 Wright Medical Technology
6.11.1 Wright Medical Technology Company Information
6.11.2 Wright Medical Technology Description and Business Overview
6.11.3 Wright Medical Technology Biologics in Spine Surgery Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Wright Medical Technology Biologics in Spine Surgery Product Portfolio
6.11.5 Wright Medical Technology Recent Developments/Updates
6.12 X-Spine
6.12.1 X-Spine Company Information
6.12.2 X-Spine Description and Business Overview
6.12.3 X-Spine Biologics in Spine Surgery Sales, Revenue and Gross Margin (2020-2025)
6.12.4 X-Spine Biologics in Spine Surgery Product Portfolio
6.12.5 X-Spine Recent Developments/Updates
6.13 Nutech
6.13.1 Nutech Company Information
6.13.2 Nutech Description and Business Overview
6.13.3 Nutech Biologics in Spine Surgery Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Nutech Biologics in Spine Surgery Product Portfolio
6.13.5 Nutech Recent Developments/Updates
6.14 Arthrex
6.14.1 Arthrex Company Information
6.14.2 Arthrex Description and Business Overview
6.14.3 Arthrex Biologics in Spine Surgery Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Arthrex Biologics in Spine Surgery Product Portfolio
6.14.5 Arthrex Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biologics in Spine Surgery Industry Chain Analysis
7.2 Biologics in Spine Surgery Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biologics in Spine Surgery Production Mode & Process Analysis
7.4 Biologics in Spine Surgery Sales and Marketing
7.4.1 Biologics in Spine Surgery Sales Channels
7.4.2 Biologics in Spine Surgery Distributors
7.5 Biologics in Spine Surgery Customer Analysis
8 Biologics in Spine Surgery Market Dynamics
8.1 Biologics in Spine Surgery Industry Trends
8.2 Biologics in Spine Surgery Market Drivers
8.3 Biologics in Spine Surgery Market Challenges
8.4 Biologics in Spine Surgery Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Biologics in Spine Surgery Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Biologics in Spine Surgery Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Biologics in Spine Surgery Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Biologics in Spine Surgery Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Biologics in Spine Surgery Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Biologics in Spine Surgery Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Biologics in Spine Surgery Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Biologics in Spine Surgery Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Biologics in Spine Surgery, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Biologics in Spine Surgery, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Biologics in Spine Surgery, Product Type & Application
 Table 12. Global Key Manufacturers of Biologics in Spine Surgery, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Biologics in Spine Surgery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics in Spine Surgery as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Biologics in Spine Surgery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Biologics in Spine Surgery Sales by Region (2020-2025) & (K Units)
 Table 18. Global Biologics in Spine Surgery Sales Market Share by Region (2020-2025)
 Table 19. Global Biologics in Spine Surgery Sales by Region (2026-2031) & (K Units)
 Table 20. Global Biologics in Spine Surgery Sales Market Share by Region (2026-2031)
 Table 21. Global Biologics in Spine Surgery Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Biologics in Spine Surgery Revenue Market Share by Region (2020-2025)
 Table 23. Global Biologics in Spine Surgery Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Biologics in Spine Surgery Revenue Market Share by Region (2026-2031)
 Table 25. North America Biologics in Spine Surgery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Biologics in Spine Surgery Sales by Country (2020-2025) & (K Units)
 Table 27. North America Biologics in Spine Surgery Sales by Country (2026-2031) & (K Units)
 Table 28. North America Biologics in Spine Surgery Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Biologics in Spine Surgery Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Biologics in Spine Surgery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Biologics in Spine Surgery Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Biologics in Spine Surgery Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Biologics in Spine Surgery Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Biologics in Spine Surgery Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Biologics in Spine Surgery Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Biologics in Spine Surgery Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Biologics in Spine Surgery Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Biologics in Spine Surgery Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Biologics in Spine Surgery Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Biologics in Spine Surgery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Biologics in Spine Surgery Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Biologics in Spine Surgery Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Biologics in Spine Surgery Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Biologics in Spine Surgery Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Biologics in Spine Surgery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Biologics in Spine Surgery Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Biologics in Spine Surgery Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Biologics in Spine Surgery Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Biologics in Spine Surgery Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Biologics in Spine Surgery Sales (K Units) by Type (2020-2025)
 Table 51. Global Biologics in Spine Surgery Sales (K Units) by Type (2026-2031)
 Table 52. Global Biologics in Spine Surgery Sales Market Share by Type (2020-2025)
 Table 53. Global Biologics in Spine Surgery Sales Market Share by Type (2026-2031)
 Table 54. Global Biologics in Spine Surgery Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Biologics in Spine Surgery Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Biologics in Spine Surgery Revenue Market Share by Type (2020-2025)
 Table 57. Global Biologics in Spine Surgery Revenue Market Share by Type (2026-2031)
 Table 58. Global Biologics in Spine Surgery Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Biologics in Spine Surgery Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Biologics in Spine Surgery Sales (K Units) by Application (2020-2025)
 Table 61. Global Biologics in Spine Surgery Sales (K Units) by Application (2026-2031)
 Table 62. Global Biologics in Spine Surgery Sales Market Share by Application (2020-2025)
 Table 63. Global Biologics in Spine Surgery Sales Market Share by Application (2026-2031)
 Table 64. Global Biologics in Spine Surgery Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Biologics in Spine Surgery Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Biologics in Spine Surgery Revenue Market Share by Application (2020-2025)
 Table 67. Global Biologics in Spine Surgery Revenue Market Share by Application (2026-2031)
 Table 68. Global Biologics in Spine Surgery Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Biologics in Spine Surgery Price (US$/Unit) by Application (2026-2031)
 Table 70. Medtronic Company Information
 Table 71. Medtronic Description and Business Overview
 Table 72. Medtronic Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Medtronic Biologics in Spine Surgery Product
 Table 74. Medtronic Recent Developments/Updates
 Table 75. J & J Company Information
 Table 76. J & J Description and Business Overview
 Table 77. J & J Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. J & J Biologics in Spine Surgery Product
 Table 79. J & J Recent Developments/Updates
 Table 80. Stryker Corporation Company Information
 Table 81. Stryker Corporation Description and Business Overview
 Table 82. Stryker Corporation Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Stryker Corporation Biologics in Spine Surgery Product
 Table 84. Stryker Corporation Recent Developments/Updates
 Table 85. Nuvasive Company Information
 Table 86. Nuvasive Description and Business Overview
 Table 87. Nuvasive Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Nuvasive Biologics in Spine Surgery Product
 Table 89. Nuvasive Recent Developments/Updates
 Table 90. Zimmer Biomet Company Information
 Table 91. Zimmer Biomet Description and Business Overview
 Table 92. Zimmer Biomet Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Zimmer Biomet Biologics in Spine Surgery Product
 Table 94. Zimmer Biomet Recent Developments/Updates
 Table 95. Orthofix International Company Information
 Table 96. Orthofix International Description and Business Overview
 Table 97. Orthofix International Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Orthofix International Biologics in Spine Surgery Product
 Table 99. Orthofix International Recent Developments/Updates
 Table 100. Globus Medical Company Information
 Table 101. Globus Medical Description and Business Overview
 Table 102. Globus Medical Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Globus Medical Biologics in Spine Surgery Product
 Table 104. Globus Medical Recent Developments/Updates
 Table 105. alphatec spine Company Information
 Table 106. alphatec spine Description and Business Overview
 Table 107. alphatec spine Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. alphatec spine Biologics in Spine Surgery Product
 Table 109. alphatec spine Recent Developments/Updates
 Table 110. K2M Company Information
 Table 111. K2M Description and Business Overview
 Table 112. K2M Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. K2M Biologics in Spine Surgery Product
 Table 114. K2M Recent Developments/Updates
 Table 115. Exactech Company Information
 Table 116. Exactech Description and Business Overview
 Table 117. Exactech Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Exactech Biologics in Spine Surgery Product
 Table 119. Exactech Recent Developments/Updates
 Table 120. Wright Medical Technology Company Information
 Table 121. Wright Medical Technology Description and Business Overview
 Table 122. Wright Medical Technology Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Wright Medical Technology Biologics in Spine Surgery Product
 Table 124. Wright Medical Technology Recent Developments/Updates
 Table 125. X-Spine Company Information
 Table 126. X-Spine Description and Business Overview
 Table 127. X-Spine Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. X-Spine Biologics in Spine Surgery Product
 Table 129. X-Spine Recent Developments/Updates
 Table 130. Nutech Company Information
 Table 131. Nutech Description and Business Overview
 Table 132. Nutech Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Nutech Biologics in Spine Surgery Product
 Table 134. Nutech Recent Developments/Updates
 Table 135. Arthrex Company Information
 Table 136. Arthrex Description and Business Overview
 Table 137. Arthrex Biologics in Spine Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Arthrex Biologics in Spine Surgery Product
 Table 139. Arthrex Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Biologics in Spine Surgery Distributors List
 Table 143. Biologics in Spine Surgery Customers List
 Table 144. Biologics in Spine Surgery Market Trends
 Table 145. Biologics in Spine Surgery Market Drivers
 Table 146. Biologics in Spine Surgery Market Challenges
 Table 147. Biologics in Spine Surgery Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Biologics in Spine Surgery
 Figure 2. Global Biologics in Spine Surgery Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biologics in Spine Surgery Market Share by Type: 2024 & 2031
 Figure 4. Bone Graft Product Picture
 Figure 5. Bone Graft Substitute Product Picture
 Figure 6. Platelet Rich Plasma (PRP) Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Biologics in Spine Surgery Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Biologics in Spine Surgery Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Other
 Figure 13. Global Biologics in Spine Surgery Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Biologics in Spine Surgery Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Biologics in Spine Surgery Sales (2020-2031) & (K Units)
 Figure 16. Global Biologics in Spine Surgery Average Price (US$/Unit) & (2020-2031)
 Figure 17. Biologics in Spine Surgery Report Years Considered
 Figure 18. Biologics in Spine Surgery Sales Share by Manufacturers in 2024
 Figure 19. Global Biologics in Spine Surgery Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Biologics in Spine Surgery Players: Market Share by Revenue in Biologics in Spine Surgery in 2024
 Figure 21. Biologics in Spine Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Biologics in Spine Surgery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Biologics in Spine Surgery Sales Market Share by Country (2020-2031)
 Figure 24. North America Biologics in Spine Surgery Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Biologics in Spine Surgery Sales Market Share by Country (2020-2031)
 Figure 28. Europe Biologics in Spine Surgery Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Biologics in Spine Surgery Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Biologics in Spine Surgery Revenue Market Share by Region (2020-2031)
 Figure 36. China Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Biologics in Spine Surgery Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Biologics in Spine Surgery Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Biologics in Spine Surgery Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Biologics in Spine Surgery Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Biologics in Spine Surgery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Biologics in Spine Surgery by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Biologics in Spine Surgery by Type (2020-2031)
 Figure 58. Global Biologics in Spine Surgery Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Biologics in Spine Surgery by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Biologics in Spine Surgery by Application (2020-2031)
 Figure 61. Global Biologics in Spine Surgery Price (US$/Unit) by Application (2020-2031)
 Figure 62. Biologics in Spine Surgery Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS